Bank of America’s ResMed RMD Stock Holding History

Bank of America’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,000	Closed	-$1.37M	–	8182
2025 Q3	$1.37M	Hold	5,000	–	–	﹤0.01%	5118
2025 Q2	$1.29M	Sell	5,000 -51,000	-91%	-$12.2M	﹤0.01%	5121
2025 Q1	$12.5M	Buy	56,000 +36,000	+180%	+$8.4M	﹤0.01%	2912
2024 Q4	$4.57M	Buy	20,000 +10,200	+104%	+$2.46M	﹤0.01%	3686
2024 Q3	$2.39M	Buy	+9,800	New	+$2.19M	﹤0.01%	4427
2017 Q4	–	Sell	-12,900	Closed	-$993K	–	7209
2017 Q3	$993K	Sell	12,900 -84,200	-87%	-$6.44M	﹤0.01%	4512
2017 Q2	$7.56M	Buy	+97,100	New	+$6.95M	﹤0.01%	2647
2015 Q1	–	Sell	-1,400	Closed	-$78K	–	7470
2014 Q4	$78K	Sell	1,400 -1,300	-48%	-$67.9K	﹤0.01%	6056
2014 Q3	$133K	Sell	2,700 -27,400	-91%	-$1.4M	﹤0.01%	5770
2014 Q2	$1.52M	Buy	30,100 +24,600	+447%	+$1.22M	﹤0.01%	3606
2014 Q1	$246K	Sell	5,500 -13,200	-71%	-$593K	﹤0.01%	5249
2013 Q4	$880K	Sell	18,700 -32,500	-63%	-$1.65M	﹤0.01%	4193
2013 Q3	$2.71M	Buy	51,200 +31,800	+164%	+$1.54M	﹤0.01%	2955
2013 Q2	$876K	Buy	+19,400	New	+$920K	﹤0.01%	4183

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America's RMD Position: Q1 2026 in Review

Bank of America increased its ResMed (RMD) stake by 12% in Q1 2026, buying an estimated $24.3M and bringing the position to 928,430 shares worth $208M. The position accounts for 0.02% of the portfolio, ranked #716.

Bank of America first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $225M in Q3 2025. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Bank of America held 928,430 shares of ResMed worth $208M as of Q1 2026.
Bank of America bought 97,406 ResMed shares in Q1 2026, an estimated $24.3M.
ResMed made up 0.02% of Bank of America's portfolio in Q1 2026, its #716 holding.
Bank of America first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
Bank of America's ResMed position peaked at $225M in Q3 2025.
940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.